These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37344428)

  • 1. Effect of Infliximab on Chronic Progressive Neuro-Behçet's Disease: Influence of the Timing of Introduction on the Patient Outcome.
    Hirohata S; Kikuchi H; Sawada T; Kuwana M; Kawachi I; Kirino Y; Ishigatsubo Y; Takeno M
    Intern Med; 2024 Feb; 63(4):481-486. PubMed ID: 37344428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.
    Yalcin Kehribar D; Gunaydin S; Ozgen M
    Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease.
    Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
    J Neurol Sci; 2015 Feb; 349(1-2):143-8. PubMed ID: 25601769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.
    Kikuchi H; Takayama M; Hirohata S
    J Neurol Sci; 2014 Feb; 337(1-2):80-5. PubMed ID: 24289890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M; Reihl M; Habek M; Vukojević N; Anić B
    Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
    Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Sequelae in Youngest Adult Behcet's Disease Patient on Infliximab.
    Sultan M; Khan A; Habib SS; Hayat M
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):762-764. PubMed ID: 32811612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of infliximab in progressive neuro-Behçet's syndrome.
    Kikuchi H; Aramaki K; Hirohata S
    J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic Progressive Neuro-Behçet's Disease].
    Hirohata S
    Brain Nerve; 2021 May; 73(5):568-575. PubMed ID: 34006690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment in refractory vascular Behcet's disease: A single-center experience.
    Kehribar DY; Ozgen M
    Vascular; 2020 Dec; 28(6):829-833. PubMed ID: 32448079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease.
    Hirohata S; Kikuchi H; Sawada T; Okada M; Takeno M; Kuwana M; Kawachi I; Mochizuki H; Kusunoki S; Ishigatsubo Y
    Intern Med; 2020 Oct; 59(19):2359-2367. PubMed ID: 32611961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].
    Kadowaki S; Matsuda N; Moriya A; Ebitani M; Yoshihara A; Nakamura K; Mochizuki H; Ugawa Y
    Rinsho Shinkeigaku; 2011 Apr; 51(4):261-6. PubMed ID: 21595295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for patients with neuro-Behcet's disease: case series and literature review.
    Borhani Haghighi A; Safari A; Nazarinia MA; Habibagahi Z; Shenavandeh S
    Clin Rheumatol; 2011 Jul; 30(7):1007-12. PubMed ID: 21431864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
    Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
    Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
    Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S; Baumgartner I; Villiger PM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):607-11. PubMed ID: 22162223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.